Mariners Rumors

AL West Notes: Trout, Rangers, Mariners, A’s

By Steve Adams | July 10, 2017 at 3:14pm CDT

After 39 games away from the team, Mike Trout is set to rejoin the Angels on Friday, per Tim Mead of the Angels’ public relations department (Twitter link). Via C.J. Daft of the Orange County Register, Trout proclaimed himself “ready to play” in the Majors following a fifth rehab game on Sunday. The Angels, incredibly, went 19-20 without Trout in the lineup, maintaining virtually the same pace at which they played when he was healthy. (Anaheim was 26-27 when Trout upon completion of the last game in which Trout played.) His return will be a boon to an Angels club that remains in the thick of the race for one of two American League Wild Card slots, though the division is effectively out of reach. Houston entered the break with a 60-29 record and is 16.5 games up over the second-place Angels.

Sherman’s Latest: Matz, Padres, Maurer, Yankees, Rangers, Smith, Mariners

By Mark Polishuk | July 9, 2017 at 7:51pm CDT

Officials from several teams tell Joel Sherman of the New York Post that this year’s deadline market is lacking in top-tier starting pitching. Jose Quintana and Sonny Gray are the top names available, though both have their share of flaws; Quintana’s rather shaky performance this year and Gray’s long-term health are concerns. With the market thin on aces, Sherman wonder if the Cardinals and Tigers would consider shopping controllable young stars Carlos Martinez or Michael Fulmer, each of whom would score an enormous return at the deadline. The Cards and Tigers could get more than the prospect package the White Sox landed for Chris Sale last winter since so many teams would be vying for those stars. It should be noted, however, that “there is no indication whatsoever” that either St. Louis or Detroit would even consider moving either pitcher.

Here’s more from Sherman in the previously-linked article and in two other pieces (first link, second link)…

Mets officials dismissed any notion of trading Steven Matz, in relation to Sherman’s consideration of teams trading controllable young arms. Elbow problems kept Matz from debuting until June, and he has a 2.12 ERA through five starts, though advanced metrics paint a much less impressive view of Matz’s performance. While the lefty would be a big trade chip if made available, it’s also certainly understandable why the Mets see him as a future building block, especially since Matz hasn’t even reached arbitration eligibility yet.
The Padres have received interest in starters Trevor Cahill, Jhoulys Chacin and Clayton Richard, as well as relievers Craig Stammen and Jose Torres.
The Yankees have already been linked to Padres reliever Brad Hand, but Sherman reports that closer Brandon Maurer’s name has also come up in talks between the two teams. Maurer has a 5.60 ERA over 35 1/3 IP for San Diego this year but he has been victimized by a inordinately low 52.9% strand rate. ERA indicators (2.95 FIP, 3.56 xFIP, 3.31 SIERA) and his peripheral numbers (8.92 K/9, 5.00 K/BB rate) paint a much more positive view of his 2017 performance. San Diego had interest in Gleyber Torres prior to his Tommy John surgery, though officials from the Padres and other teams believe that the Yankees’ farm system is deep enough that they’ll be able to make deals without moving any of their top prospects.
Control may be more of a commodity than pure talent in the reliever market, according to one NL executive. “My sense is that if you have a reliever who is under control through at least next year, you can expect more interest and a greater return than for a slightly better reliever who is a free agent after this season,” the executive said.
One team is looking to add controllable pieces both its bullpen and in general is the Rangers, in a return to their strategy from the 2015 deadline. One AL official feels Texas will add one or two relievers, and whomever the Rangers may add, “I would be shocked if that player did not have control through at least next season.”
The Red Sox are still waiting to see if Carson Smith can be a bullpen asset for them this season before fully exploring the relief market. Smith is expected to start mound work this week as he continues his rehab from Tommy John surgery, though his process was already delayed when he was shut down from throwing for a spell last month. Given that it would surprising to see Smith even return to action before July 31, one would think Boston will end up looking at relief help and counting on Smith only as a potential bonus down the stretch.
The Mariners are one of only a few teams open to adding payroll in deadline trades, which one official describes as not “as good as having prospects, but it is an asset.” The M’s began 2017 with a record payroll of more than $155.2MM, so with such a major financial investment already made, it makes sense that GM Jerry Dipoto and company are willing to spend a bit more to get the team over the hump. Dipoto recently stated that the team is still planning to add at the deadline, though Seattle ends the first half with a 43-47 record (albeit four games out of a wild card spot).

AL Notes: Trade Chatter, Richards, M’s, Rangers, Profar, Draft

By Jeff Todd | July 8, 2017 at 12:53am CDT

The trade deadline chatter hasn’t really picked up yet, perhaps in large part owing to the tightly packed American League. Jon Heyman of Fan Rag recently took his weekly spin around the A.L., providing a few items of note. While there has been a bit of buzz around Justin Verlander, the Tigers haven’t asked him to provide a list of teams to which he’d permit a trade. The Astros, meanwhile, seem to be hoping for a chance at adding a difference-making starter, but don’t know whether such an arm will end up being made available. And the White Sox, unsurprisingly, are ready and willing to get deals done.

Here’s more from the American League:

It’s still not clear when the Angels can expect righty Garrett Richards to return, but Pedro Moura of the Los Angeles Times provides an update (Twitter links). The biceps nerve irritation he has experienced isn’t completely relieved, but it has improved. Just when he’ll be cleared to throw, though, has yet to be determined — and no doubt there’ll be a lengthy and cautious build-up once the medical staff gives a go-ahead.
Mariners GM Jerry Dipoto suggests that he still doesn’t perceive a need to shake things up too drastically at the deadline, despite a lull that has the M’s now sitting four games under .500. As MLB.com’s Greg Johns reports, Dipoto says that the team’s “roster plan has never really changed.” While buy and sell-side opportunities could arise at the deadline, it seems a major shift in either direction is unlikely. Starting pitching, clearly, is a prime need. “We’re not going to empty both barrels to try to go out and find the ace to perch atop the rotation to take us to the promised land, because that guy doesn’t exist,” said Dipoto. But he also noted that the trade deadline is but one of “two windows when you can access starting pitching” and promised at least to “stay in tune with” the market for starters.
There’s a similar sentiment in Texas, it seems. It would take “unique circumstances” for the Rangers to sell veteran players at the deadline, GM Jon Daniels tells Jeff Wilson of the Forth Worth Star-Telegram. While Texas is likely only competing for a Wild Card at this point, neither is the organization facing any need to trim salary, per the report. With confidence within the organization seemingly still running high, it appears the likeliest scenario is that the team will mostly look to maintain its roster through the non-waiver trade period.
Meanwhile, it’s still unclear what will happen with Rangers infielder/outfielder Jurickson Profar, as Wilson writes. Presumably, the still youthful former top prospect could end up playing a significant role with Texas or be utilized as a trade chip over the summer. For the time being, he’s receiving only brief stints in the majors. Regardless of how things turn out, Profar says that he’s dealing with things by playing his hardest wherever that may be — mostly, this year, at Triple-A. He has hit well at Round Rock, slashing .303/.376/.444 in 223 plate appearances this year, and would still be an interesting trade candidate to dangle this summer.
The Rays failed to sign supplemental first-round draft pick Drew Rasmussen, as MLB.com’s Jim Callis first tweeted. It seems that Rasmussen will not be turned loose in free agency, as John Manuel of Baseball America writes; instead, he’ll likely head back to Oregon State for his senior year. Tampa Bay, meanwhile, is still hoping the league will award it a compensatory pick in next year’s draft. (While the organization did not make a sufficient offer to do so, it feels that there were issues with Rasmussen’s pre-draft MRIs.) Meanwhile, Orioles fourth-rounder Jack Conlon will be granted unrestricted free agency after going unsigned, as BA’s Hudson Belinsky explains. That gives him the option of signing on with any MLB organization — without being capped by bonus pools — or instead heading to college. Angels fifth-rounder Joe Booker was the only other player from the first ten rounds of the draft to go unsigned, as Belinsky tweeted he’ll instead honor a commitment to South Alabama.

Hisashi Iwakuma Receives Shoulder Injections After Setback

By Jeff Todd | July 4, 2017 at 6:03pm CDT

Mariners righty Hisashi Iwakuma is not progressing as had been hoped, as Ryan Divish of the Seattle Times reports. Following another setback, he has received cortisone and platelet-rich plasma injections in his troublesome right shoulder.

The hope, of course, is that this course of treatment will spur healing and finally allow Iwakuma to maintain steady progress. But the expectation had been that the veteran starter would long since have advanced back to the majors.

Seattle’s rotation is in better shape now than it has been at times, with Felix Hernandez and James Paxton returning and rookie Andrew Moore showing well in his first two MLB starts. Ariel Miranda and Sam Gaviglio are producing solid results, though their peripherals portend some regression.

Still, Iwakuma’s halting recovery is an ongoing concern for a club that continues to hover around .500 — along with much of the rest of the American League. Indeed, Divish notes that there’s at least a strand of thinking in the organization of the belief that Iwakuma won’t contribute again this season.

It’s still anyone’s guess just how the M’s will approach the deadline with the division out of reach but a Wild Card berth still fully plausible. Seattle will have an opportunity to see how Iwakuma progresses over the next three weeks or so, and the on-field results will also impact the calculus. If the team looks into additions, though, the rotation arguably represents the primary area of need — particularly with southpaw Drew Smyly now ruled out for the year following Tommy John surgery.

Minor MLB Transactions: 7/3/17

By Steve Adams | July 3, 2017 at 10:07pm CDT

Here are Monday’s minor moves from around the game…

Infielder Tony Renda has been dealt from the Reds to the Diamondbacks in exchange for a player to be named later or cash considerations, MLB.com’s Mark Sheldon tweets. The 26-year-old had been outrighted over the winter after struggling in his MLB debut last year. Through 198 plate appearances at Triple-A in 2017, he was slashing just .260/.305/.326 — albeit with just 18 strikeouts to go with a dozen walks.
In another minor swap, the Giants purchased Tyler Herb from the Mariners for an undisclosed sum, both teams announced. He’ll actually represent the player to be named later in the deal that sent Chris Heston to Seattle, Henry Schulman of the San Francisco Chronicle tweets, with some undisclosed technicality requiring the particular treatment. The 25-year-old was taken in the 29th round of the 2014 draft. He made it up to the Double-A level last year and has thrown well there upon a repeat assignment. Herb has made it through 98 innings in 16 starts on the year, posting a 3.31 ERA with 8.1 K/9 against 2.8 BB/9.
Nationals righty Jacob Turner has accepted an outright assignment after clearing waivers, per a team announcement. Still just 26, Turner has given the Nats some badly needed innings this year, though his ERA stands at 5.08 after 39 frames of action. He is expected to resume working as a starter in case he’s needed in that role at the major league level.
Also outrighted was Blue Jays outfielder Ian Parmley, Toronto announced. He was up for a brief stretch, but will return to plying his trade at Triple-A Buffalo. over 205 plate appearances there on the year, Parmley is slashing .289/.332/.369.
The Mariners released southpaw Nick Hagadone, according to Triple-A Tacoma announcer Mike Curto (via Twitter). As Curto notes, Hagadone has been particularly impressive of late. The 31-year-old has seen action in parts of four MLB seasons, all with the Indians, but missed all of last year after an elbow fracture. He landed in Seattle on a minors deal and has thrown 33 1/3 innings of 3.51 ERA ball — with 9.5 K/9 against 3.5 BB/9 — since arriving in Tacoma. (It could well be, then, that Hagadone utilized an opt-out clause, though we’ve heard no indication of that as of yet.)

Earlier Transactions

The Brewers announced that they’ve selected the contract of right-hander Michael Blazek from Triple-A Colorado Springs. The 28-year-old was outrighted off the 40-man roster earlier this year but remained in the organization and has posted a solid 3.13 ERA in that extremely hitter-friendly setting. While all of Blazek’s 104 career appearances in the Majors have been in relief, he’s been working as a starter for his past 10 trips to the hill in Triple-A. MLB.com’s Adam McCalvy suggests (via Twitter) that Blazek could very well pitch today in relief of left-hander Brent Suter. Piggybacking the two would certainly make some sense, as Suter may not be fully stretched out with his most recent start coming back on June 13. Milwaukee already had an open spot on the 40-man, so there’s no corresponding 40-man move needed to accommodate Blazek.

AL International Signings: 7/2/17

By Mark Polishuk | July 2, 2017 at 9:23am CDT

Here are some notable American League international signings not yet covered elsewhere on MLB Trade Rumors. All signing information can be found in these invaluable compilations of the initial flurry of July 2 action from Baseball America’s Ben Badler and MLB.com’s Jesse Sanchez; the information here is from those sources unless otherwise credited…

The Yankees have agreed to sign Venezuelan outfielder Everson Pereira and shortstop Roberto Chirinos. Pereira will receive a $1.5MM bonus, while Chirinos gets $900K. The Yankees are also seen as the favorites to sign Dominican shortstop Ronny Rojas, with Sanchez projecting a $1.05MM bonus. Badler tweets that Rojas isn’t eligible to officially sign until August, when he turns 16 years old.
The Blue Jays have reached agreement with Brazilian right-hander Eric Pardinho on a $1.4MM bonus, as well as signing Dominican shortstop Miguel Hiraldo to a $750K deal.
The Tigers agreed to sign Venezuelan shortstop Alvaro Gonzalez for a $1MM bonus.
The Indians have reached deals with Venezuelan shortstop Aaron Bracho ($1.5MM) and Dominican outfielder George Valera ($1.3MM according to Sanchez, $1.2MM according to Badler).
The Angels signed Bahamanian outfielder Trent Deveaux, with Jeff Fletcher of the Orange County Register reporting that Deveaux will receive a $1.2MM bonus.
The Mariners have a $1.75MM agreement with Dominican outfielder Julio Rodriguez, as well as a $1.225MM agreement with Venezuelan shortstop Juan Querecuto.
The Rangers agreed to nine-figure deals with a trio of prospects. Venezuelan outfielder Wilderd Patino will receive a $1.3MM bonus, while Venezuelan shortstop Keyber Rodriguez and Mexican right-hander Damian Mendoza each get bonuses worth $1MM.

Mariners Outright Pat Light

By Jeff Todd | June 28, 2017 at 2:37pm CDT

The Mariners have outrighted right-handed pitcher Pat Light, per a club announcement. That opens a 40-man roster spot, though it’s not immediately clear whether the team has plans for how to use it.

Seattle claimed the 26-year-old Light off waivers from the Pirates just under two weeks ago, though his stay on the 40-man was brief. Light has gone from the Red Sox to the Twins (in exchange for Fernando Abad) to the Pirates (for cash) to the Mariners all in a span of roughly 11 months.

It’s not hard to see the appeal of Light, who runs his fastball up to the upper 90s and averages nearly 95 mph on the pitch. He’s had no trouble missing bats in the minors and turned in a tantalizing 2.37 ERA with 9.9 K/9 against 4.5 BB/9 in 38 Triple-A frames last season. However, control problems have plagued the hard-throwing Light throughout his career (63 walks in 99 Triple-A innings), and he’s posted particularly unremarkable numbers in Triple-A this season. Through 28 innings between the Triple-A affiliates for the Pirates and Mariners, Light has a 4.82 ERA with a greatly diminished 6.4 K/9 rate and a still-problematic 5.8 BB/9 rate.

Drew Smyly To Undergo Tommy John Surgery

By Jeff Todd | June 28, 2017 at 12:25pm CDT

The Mariners have announced that lefty Drew Smyly will undergo Tommy John surgery for a torn ulnar collateral ligament. He is expected to miss the standard twelve to fifteen months in recovery.

That’s obviously devastating news for the 28-year-old southpaw, who had been hoping to work back from elbow issues that have put him on the shelf all year. He had shown quite well in the World Baseball Classic, with enhanced velocity, leading to hopes for a big first season in Seattle.

Instead, it now seems possible that Smyly won’t ever make an appearance for the M’s, who traded Mallex Smith and others to acquire his rights over the winter. Smith had been added earlier that day in a clearly related swap that sent pitching prospect Luiz Gohara to the Braves.

Smyly is earning $6.85MM this year and would command the same through arbitration in 2018 — his final trip through the process. It’s still possible that Seattle could attempt to work out some kind of arrangement to keep him in the organization for the future, but it obviously makes little sense for the team to pay him a significant salary for a year that will be spent rehabbing.

Last year was a rough one for the southpaw, who scuffled to a 4.88 ERA over 175 1/3 innings, though it also represented his first thirty-start campaign in the big leagues. He also still managed a healthy 8.6 K/9 against 2.5 B/9, with 32 home runs and a below-average 67.7% strand rate contributing to the ugly results.

Given his age, Smyly still has a shot at returning for many more years of pitching. Of course, he’ll need not only to work back from the UCL replacement, but also to find a way to avoid future elbow problems. (He had been among the highest-risk players identified by MLBTR contributor Bradley Woodrum in a 2016 study, and the risks for another will only increase.)

For the Mariners, the news confirms what the club surely already feared: there won’t be a reinforcement coming to the team in 2017. With Felix Hernandez and Hisashi Iwakuma showing their age, and James Paxton coming back down to earth of late, there are questions at the front of the staff.

There are depth concerns, too. While Sam Gaviglio owns a 3.38 ERA through 45 1/3 innings, the metrics don’t like his chances to maintain that performance. Similarly, Ariel Miranda has been solid but is benefiting from a likely-unsustainable .226 BABIP. It’s anyone’s guess what the team can hope to receive from Andrew Moore and others.

The fact that there’s a potential need doesn’t mean that the M’s can afford to go out and add a top-line starter, of course. Several quality arms could be available, of course, but there’ll be competition and steep asking prices. While Seattle has positioned itself as a win-now organization, it’s also a notable consideration that the AL West seems out of reach, meaning any present-focused moves come with the likely upside of earning a Wild Card berth.

Pitching Injury Notes: Smyly, Weigel, Keuchel, Nats, Salazar, Hendricks, Finnegan

By Jeff Todd | June 28, 2017 at 8:50am CDT

The Mariners got some unwelcome news about the status of rehabbing lefty Drew Smyly. As Ryan Divish of the Seattle Times, plans for Smyly to face live hitting were scuttled after the southpaw experienced some elbow discomfort. Pitching coach Mel Stottlemyre explains that Smyly has dealt with other such “episodes” while working back from a flexor strain, especially when throwing breaking pitches, so perhaps this could just be a minor blip. Still, he’s slated for a medical examination; at present, there’s no clear indication of what’ll come next. “Until the doctors check, and all that stuff subsides, you just can’t move forward,” explains Stottlemyre. “It’s hard to make a plan going forward until we know more.”

Clearly, Seattle’s deadline plans could be altered by Smyly’s progress (or lack thereof). If the team finds itself in a strong Wild Card position at the end of July, but doesn’t think it’ll get the rotation boost it needs, it’s at least possible to imagine a move to bolster the rotation. Here are some more notable injury situations from around the game:

Young Braves hurler Patrick Weigel is headed for Tommy John surgery, per David O’Brien of the Atlanta Journal-Constitution. That’s the result that was feared when it was learned that he had suffered a partial UCL tear. Soon to turn 23, Weigel had reached Triple-A in just his third professional season. He could’ve conceivably provided the Braves with a rotation option for 2018, so the loss should only increase the organization’s interest in adding a significant outside starter.
It seems the Astros are wisely taking a measured approach with southpaw Dallas Keuchel, who is working back from a pinched nerve in his neck. As Jake Kaplan of the Houston Chronicle writes, skipper A.J. Hinch acknowledges that the club is “just being conservative” by “methodically putting a few more challenges in front of him” to bring Keuchel along slowly. With Keuchel in need of at some rehab outings before returning to the MLB hill, it seems he won’t likely make it back until after the All-Star break. That timeline surely works just fine for the front-running Astros, who are as close to a postseason shoe-in as there can be at this stage of the season.
The Nationals’ bullpen needs have long been a focus of the 2017 trade season. Just how many arms the Nats will go looking for could well depend in part upon the progress of several current pitchers. Per a club update, via Mark Zuckerman of MASNsports.com (via Twitter), Sammy Solis appears to be making real strides after missing a significant stretch with elbow issues, as he was able to take the ball for Triple-A Syracuse. If the power lefty can return to health and to form, that’d be a significant boost. Meanwhile, Shawn Kelley (out with a trap strain) has resumed throwing — which is not yet the case for fellow righty Koda Glover (who is dealing with back issues).
There’s some positive momentum for Indians righty Danny Salazar, as Jimmy Miller of the Akron Beacon Journal writes. Salazar says his shoulder feels good, and he’s now slated to begin a rehab assignment. The high-octane hurler, 27, could potentially re-take a spot in the rotation or provide Cleveland with another fascinating, multi-inning-capable bullpen arm.
Likewise, the Cubs saw progress from righty Kyle Hendricks, as Patrick Mooney of CSN Chicago tweets that he was able to throw (albeit only from 90 feet) without experiencing any issues in his hand. Hendricks has been dealing with tendon problems in his pitching hand, leading to a DL placement. Before going down with the injury, Hendricks had turned in eleven somewhat worrying starts. Expectations were high after he landed third in the 2016 Cy Young voting, but Hendricks has shown a significant velocity loss (over two miles per hour on his fastball) and a big drop in swinging-strike rate (from 10.0% to 7.3%). Getting him healthy and back to form would represent a big boost to the Cubs, though it’s not clear whether they’ll have a real read on his capacity before making deadline plans.
While the Reds haven’t yet made a move, it seems likely that lefty Brandon Finnegan is heading back to the DL. Initial indications were that he had only experienced a triceps strain during his first start after rehabbing an injury to the teres major muscle in his shoulder. Instead, per manager Bryan Price (on MLB Network Radio on Sirius XM, via Twitter), the injury was traced to that same muscle. While it’s said to be in a different part of the muscle, it nevertheless seems rather concerning that Finnegan is experiencing issues in that same narrow area. The broader prognosis remains unclear at this moment, though Price said he expects the southpaw to miss “at least … several weeks, if not longer.”

AL Notes: Sox, Mariners, Rays, Angels

By Connor Byrne | June 25, 2017 at 12:02pm CDT

Red Sox third base prospect Rafael Devers is making a case for a promotion in Double-A, but the team still isn’t ready to summon the 20-year-old to the majors, writes Jason Mastrodonato of the Boston Herald. Devers, Baseball America’s 14th-ranked prospect, has slashed .289/.346/.550 with 14 home runs in 272 plate appearances this year and impressed Red Sox vice president of player development Ben Crockett along the way. “It’s been a really positive year,” Crockett said of Devers. “He’s learned a lot. Playing with older teammates, more experienced guys, it’s a different life experience. I think it’s been great for him. The staff, with manager Carlos Febles, has done a great job being consistent with him. He’s a great worker. He’s passionate and cares about what he’s doing.” Crockett’s glowing review aside, the Red Sox are hesitant to call up a prospect unless they know he’ll play every day, notes Mastrodonato, who suggests they’ll look to acquire a veteran third baseman by the trade deadline. Whether help comes in the form of a veteran or Devers, Boston is in serious need of aid at the hot corner. The club’s third basemen rank last in the majors in wRC+ (a pitiful 44) and fWAR (minus-1.3).

Headlines

Mariners Rumors

Navigation

MLBTR INFO

Connect